En español
NIDA

Agenda

122nd Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

February 10, 2016

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

8:30 a.m.

Call to Order
Nora Volkow, M.D. Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.,
Executive Secretary,
National Advisory Council on Drug Abuse,
Director, Division of Extramural Research, NIDA

8:45 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Division of Therapeutics and Medical Consequences (DTMC)
Phil Skolnick, Ph.D., D.Sc. (hon.), Director

Division of Neuroscience and Behavioral (DNB)
Joni Rutter, Ph.D., Director

10:00 a.m. End of Closed Session/Break

WebEx Information (Open Session Only)

Topic: WebEx - 2016 NIDA Advisory Council on Drug Abuse Meeting
Date and Time: Wednesday, February 10, 2016 10:30 am, Eastern Standard Time (New York, GMT-05:00
Event number: 668 143 075

To start the online event

At least 30 minutes before the starting time:

  1. Go to https://nida-events.webex.com/nida-events/onstage/g.php?MTID=e85aee4272808c9dbba2a8cdee4a2b2d6
  2. If requested, enter in your name and email address.
  3. If a password is required, enter in the meeting password: Success1
  4. Click “Join”.

Audio conference information Telephone Conference for this Meeting: Call-in Phone No.: 1-866-672-0440

Open Session

10:30 a.m. Opening and Welcome New Members​
Nora Volkow, M.D. Director, NIDA
10:45 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
11:45 a.m. Council Discussion
Council Members
12:00 p.m. Lunch Break (Steering Group Meeting)​
1:00 p.m. Genotype-Tissue Expression (GTex) Project
Kristin Ardlie, Ph.D.
Project Director,
Biological Samples Platform
Broad Institute of Harvard and MIT
1:45 p.m. New AIDS Priorities
Bob Eisinger
Acting Associate Director,
AIDS Research, NIH
2:30 p.m. Break
2:45 p.m. Changing Landscape of Tobacco Products: Proposed Refresh of NACDA Document-Points to Consider Regarding TobaccoIndustry Funding of NIDA Applicants​
Laura Bierut, M.D.
NACDA Council Member, and
Professor of Psychiatry
Washington University School of Medicine
St. Louis, MO
3:00 p.m. FOA Concept Clearances
NIDA Staff

SBIR Program FY 17 FOA Concepts
  • Entrepreneurial Training for Addiction Researchers
  • Improved Technologies and Ligands for Non-Invasive Brain Imaging
  • Laboratory and Diagnostic Tools to Advance Microbiome-Brain Research
HIV/AIDS Program FY17 FOA Concepts
  • Optimizing the HIV Care Continuum for Substance Abuse Populations Living with HIV
  • Implication of Cholinergic Regulation of Immune Function in HIV Infectivity and Pathogenesis
  • Mobilizing Seek, Test, Treat, and Retain Approaches in Rural Opioid Drug Use Epidemics
  • Coordinating Center for the HIV/AIDS Substance Use Cohorts Program
  • Mechanisms of Immune Activation and Inflammation in Drug-Abusing HIV-Infected Patients on ART
4:20 p.m. Public Comments
4:30 p.m. Adjourn

This page was last updated February 2016